Rotherham, Doncaster and South Humber NHS Foundation Trust (RDaSH) patient group direction (PGD) for the administration of topical lidocaine 2.5% plus prilocaine 2.5% cream (EMLA Cream 5% or Nulbia 5% cream) to facilitate intrauterine contraception (IUC) insertion or removal.
This template protocol, for local adaptation, has been peer reviewed by the reproductive health PGD protocols short life working group in accordance with their terms of reference. It has been approved by the faculty for sexual and reproductive health (FSRH) in November 2022.
To download this PGD please follow the link: Lidocaine plus prilocaine cream PGD v1.
To access the equality impact assessment for this policy, please see the overarching equality impact assessment.
Page last reviewed: April 30, 2024
Next review due: April 30, 2025